Addus HomeCare (NASDAQ:ADUS) Issues Quarterly Earnings Results, Beats Estimates By $0.14 EPS

Addus HomeCare (NASDAQ:ADUS) posted its earnings results on Monday. The company reported $1.35 EPS for the quarter, topping the consensus estimate of $1.21 by $0.14, Briefing.com reports. Addus HomeCare had a net margin of 6.04% and a return on equity of 10.03%. The company had revenue of $286.90 million during the quarter, compared to the consensus estimate of $284.90 million. During the same period in the previous year, the firm posted $0.94 earnings per share. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year.

Addus HomeCare Stock Performance

ADUS traded down $3.16 during midday trading on Wednesday, reaching $121.34. The company’s stock had a trading volume of 73,613 shares, compared to its average volume of 136,372. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.14. The company has a fifty day simple moving average of $118.43 and a 200 day simple moving average of $105.29. The stock has a market cap of $2.20 billion, a P/E ratio of 30.89, a PEG ratio of 2.35 and a beta of 1.01. Addus HomeCare has a twelve month low of $78.35 and a twelve month high of $126.70.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on ADUS. Oppenheimer lifted their price objective on shares of Addus HomeCare from $130.00 to $140.00 and gave the company an “outperform” rating in a research note on Wednesday. Macquarie began coverage on Addus HomeCare in a research report on Friday, June 28th. They issued an “outperform” rating and a $136.00 price target for the company. Bank of America increased their price objective on Addus HomeCare from $115.00 to $118.00 and gave the company a “buy” rating in a report on Tuesday, May 7th. StockNews.com lowered Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Sunday, July 7th. Finally, Stephens reaffirmed an “overweight” rating and set a $138.00 target price on shares of Addus HomeCare in a research report on Tuesday. One equities research analyst has rated the stock with a sell rating and eight have issued a buy rating to the company. According to MarketBeat, Addus HomeCare presently has an average rating of “Moderate Buy” and an average price target of $120.71.

Insider Transactions at Addus HomeCare

In related news, EVP Roberton James Stevenson sold 217 shares of the company’s stock in a transaction on Monday, June 17th. The shares were sold at an average price of $116.13, for a total transaction of $25,200.21. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares in the company, valued at approximately $1,186,500.21. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 4.60% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.